FRE — Fresenius SE & Co. KGaA Share News
0.000.00%
Last trade - 00:00- €26.47bn
- €35.49bn
- €22.87bn
Healthcare firm Fresenius Q3 revenue rises on Kabi growth; lifts outlook
Brief: Fresenius Sees FY26 EBIT Margin Above 11.5%
Brief: Fresenius SE Q3 Revenue EUR 5,803 Million
Fresenius signs biosimilars pipeline agreement with WuXi Biologics (updated)
Fresenius signs biosimilars pipeline agreement with WuXi Biologics
Refile: BRIEF-Fresenius And Wuxi Biologics Enter Exclusive Development Agreement To Expand Biosimilars Pipeline
Europe Research Roundup: Fresenius, L'Oreal, SAP
Europe Research Roundup: AJ Bell, CMC Markets, Nestle
Brief: Fresenius Supervisory Board Appoints Dr. Marc-Alexander Mahl To Fresenius Management Board
Brief: Fresenius Medical Care Appoints Shervin J. Korangy As Chairman Of Management Board Effective Oct 12
Brief: Fresenius Buys Remaining 45% Of Mabxience For Up To Eur 750 Mln
Brief: Fresenius Expands European Production Capacity
Brief: Fresenius Raises Approximately €300 Million Through Sale Of 7.8 Million Fresenius Medical Care Shares
Brief: Fresenius SE - To Convert Bearer Shares Into Registered Shares
Fresenius rises after co ups outlook, reports Q2 adj. EBIT beat
Fresenius raises 2026 outlook after Q2 profit beat
Germany's Fresenius raises 2026 core EPS growth guidance
Germany's Fresenius SE Q2 core EPS rises 14%, lifts 2026 outlook
Brief: Fresenius Reports Q2 Revenue EUR 5,864 Million